Stay updated with breaking news from Exploratory Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...
The characteristics & related factors for having no vision survival following Open Globe Injury in a tertiary referral center located in a non-industrial area.
/PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches...
/PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches...
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence...